Insider · CIK 0001777421
Laura Sepp-Lorenzino
Files at NTLA (Intellia Therapeutics, Inc.), TSHA (Taysha Gene Therapies, Inc.). First filing Jan 7, 2025, latest Jan 7, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NTLA: Intellia Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Intellia Therapeutics, Inc. | $109k 8,966 shares | -10% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 2, 2025 | TSHA Taysha Gene Therapies, Inc. | AGrant or award Common Stock | +56,623 | $0.00 | $0 | 105,843 | Jun 4, 2025 |
| Jun 2, 2025 | TSHA Taysha Gene Therapies, Inc. | AGrant or award Stock Option (right to buy)derivative | +113,246 | $0.00 | $0 | 113,246 | Jun 4, 2025 |
| Jan 3, 2025 | NTLA Intellia Therapeutics, Inc. | SOpen-market sale Common Stock | -8,966 | $12.18 | $109k | 77,388 | Jan 7, 2025 |
| Jan 1, 2025 | NTLA Intellia Therapeutics, Inc. | MOption exercise Common Stock | +3,500 | - | - | 86,354 | Jan 3, 2025 |
| Jan 1, 2025 | NTLA Intellia Therapeutics, Inc. | MOption exercise Restricted Stock Unitderivative | -3,500 | $0.00 | $0 | 0 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.